/PRNewswire/ The "Targeted Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This report provides strategists,.
Drugs developer ChemGenex has completed the second phase of a $21 million capital raising to help it complete the development of its Leukemia drug Ceflatonin.